Description

Soleron 200 (amisulpride) tablets 200 mg. №30

Ingredients

Active ingredient: Amisulpride 200 mg per tablet.

Dosage

Recommended dosage: The usual dose is 200-800 mg daily, divided into two doses.

Indications

Soleron 200 tablets are indicated for the treatment of schizophrenia.

Contraindications

Do not use Soleron 200 tablets if you are allergic to amisulpride or any other ingredients in the product.

Directions

Take Soleron 200 tablets orally with or without food as directed by your doctor.

Scientific Evidence

Amisulpride, the active ingredient in Soleron 200 tablets, is a second-generation antipsychotic that primarily works by blocking dopamine D2 and D3 receptors. Studies have shown that amisulpride is effective in treating both positive and negative symptoms of schizophrenia. Research published in the Journal of Clinical Psychopharmacology demonstrated the efficacy of amisulpride in improving overall symptoms and quality of life in patients with schizophrenia.

Additional Information

It is important to follow your healthcare provider’s instructions carefully when taking Soleron 200 tablets. If you experience any severe side effects or allergic reactions, seek medical help immediately. Keep this medication out of reach of children and store it at room temperature away from moisture and heat.

Amisulpride’s pharmacological action involves its selective blockade of dopamine D2 and D3 receptors in the brain, leading to an improvement in psychotic symptoms. Unlike some other antipsychotic medications, amisulpride has a lower risk of causing weight gain and metabolic disturbances, making it a favorable choice for many patients.

Clinical trials have shown that Soleron 200 tablets are as effective as other antipsychotic medications with a more favorable side effect profile. Patients taking Soleron 200 tablets reported improvements in symptoms such as hallucinations, delusions, and disorganized thinking. The medication’s tolerability and effectiveness make it a valuable option in the management of schizophrenia.